Matches in SemOpenAlex for { <https://semopenalex.org/work/W2035528736> ?p ?o ?g. }
- W2035528736 endingPage "270" @default.
- W2035528736 startingPage "259" @default.
- W2035528736 abstract "Angiosarcomas are rare, aggressive vascular tumours known to express vascular endothelial growth factor (VEGF), a key pro-angiogenic growth factor. The aim of this study was to determine the potential effects of vascular-targeted agents for the treatment of angiosarcoma, using two human cutaneous angiosarcoma cell lines (ASM and ISO-HAS), and human dermal microvascular endothelial cells (HuDMECs) for comparison. Protein arrays were used to assess the expression of angiogenesis-related proteins, and potential drug targets were assessed by ELISA and Western blotting. Response to vascular-targeted agents, including bevacizumab an anti-VEGF antibody, axitinib a VEGF-receptor tyrosine kinase inhibitor, everolimus an mTOR inhibitor, selumetinib a MEK inhibitor and vadimezan a vascular-disrupting agent were compared in functional in vitro cellular assays, including viability, differentiation and migration assays. ASM and ISO-HAS cells expressed a broad range of pro-angiogenic growth factors. ASM and ISO-HAS VEGF expression was significantly increased (p = 0.029) compared with HuDMECs. Striking responses were seen to vadimezan with an IC50 of 90 and 150 μg/ml for ASM and ISO-HAS cells, respectively. Selumetinib inhibited ASM with an IC50 of 1,750 ng/ml, but was not effective in ISO-HAS. Everolimus reduced both ASM and ISO-HAS viable cell counts by 20 % (p < 0.001). Minimal responses were observed to bevacizumab and axitinib in assays with ASM and ISO-HAS cells. Further studies are warranted to investigate mTOR inhibitors, MEK inhibitors and vascular-disrupting agents for the treatment of angiosarcoma." @default.
- W2035528736 created "2016-06-24" @default.
- W2035528736 creator A5004384935 @default.
- W2035528736 creator A5016753393 @default.
- W2035528736 creator A5040551223 @default.
- W2035528736 creator A5062272686 @default.
- W2035528736 creator A5073514635 @default.
- W2035528736 date "2013-11-20" @default.
- W2035528736 modified "2023-09-23" @default.
- W2035528736 title "Vascular-targeted agents for the treatment of angiosarcoma" @default.
- W2035528736 cites W1559201260 @default.
- W2035528736 cites W1985125414 @default.
- W2035528736 cites W1996252991 @default.
- W2035528736 cites W2000292756 @default.
- W2035528736 cites W2016396157 @default.
- W2035528736 cites W2018777580 @default.
- W2035528736 cites W2026144900 @default.
- W2035528736 cites W2045769280 @default.
- W2035528736 cites W2054058572 @default.
- W2035528736 cites W2056304545 @default.
- W2035528736 cites W2062859168 @default.
- W2035528736 cites W2064428124 @default.
- W2035528736 cites W2068852777 @default.
- W2035528736 cites W2079150475 @default.
- W2035528736 cites W2096514095 @default.
- W2035528736 cites W2106932520 @default.
- W2035528736 cites W2108517627 @default.
- W2035528736 cites W2123312554 @default.
- W2035528736 cites W2124148984 @default.
- W2035528736 cites W2127278176 @default.
- W2035528736 cites W2142170680 @default.
- W2035528736 cites W2144530818 @default.
- W2035528736 cites W2145534249 @default.
- W2035528736 cites W2153493705 @default.
- W2035528736 cites W2158493799 @default.
- W2035528736 cites W2161032069 @default.
- W2035528736 cites W2168977372 @default.
- W2035528736 cites W2170583701 @default.
- W2035528736 cites W2170973522 @default.
- W2035528736 cites W2317902166 @default.
- W2035528736 cites W3117975060 @default.
- W2035528736 cites W4241497580 @default.
- W2035528736 cites W4242016168 @default.
- W2035528736 doi "https://doi.org/10.1007/s00280-013-2345-0" @default.
- W2035528736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24253175" @default.
- W2035528736 hasPublicationYear "2013" @default.
- W2035528736 type Work @default.
- W2035528736 sameAs 2035528736 @default.
- W2035528736 citedByCount "19" @default.
- W2035528736 countsByYear W20355287362014 @default.
- W2035528736 countsByYear W20355287362015 @default.
- W2035528736 countsByYear W20355287362016 @default.
- W2035528736 countsByYear W20355287362017 @default.
- W2035528736 countsByYear W20355287362019 @default.
- W2035528736 countsByYear W20355287362020 @default.
- W2035528736 countsByYear W20355287362021 @default.
- W2035528736 countsByYear W20355287362022 @default.
- W2035528736 countsByYear W20355287362023 @default.
- W2035528736 crossrefType "journal-article" @default.
- W2035528736 hasAuthorship W2035528736A5004384935 @default.
- W2035528736 hasAuthorship W2035528736A5016753393 @default.
- W2035528736 hasAuthorship W2035528736A5040551223 @default.
- W2035528736 hasAuthorship W2035528736A5062272686 @default.
- W2035528736 hasAuthorship W2035528736A5073514635 @default.
- W2035528736 hasBestOaLocation W20355287362 @default.
- W2035528736 hasConcept C121608353 @default.
- W2035528736 hasConcept C126322002 @default.
- W2035528736 hasConcept C142724271 @default.
- W2035528736 hasConcept C167734588 @default.
- W2035528736 hasConcept C184235292 @default.
- W2035528736 hasConcept C2776087337 @default.
- W2035528736 hasConcept C2776539811 @default.
- W2035528736 hasConcept C2777025900 @default.
- W2035528736 hasConcept C2778820342 @default.
- W2035528736 hasConcept C2779217266 @default.
- W2035528736 hasConcept C2779490328 @default.
- W2035528736 hasConcept C2779699572 @default.
- W2035528736 hasConcept C2780394083 @default.
- W2035528736 hasConcept C2781249067 @default.
- W2035528736 hasConcept C502942594 @default.
- W2035528736 hasConcept C57074206 @default.
- W2035528736 hasConcept C71924100 @default.
- W2035528736 hasConcept C86803240 @default.
- W2035528736 hasConcept C95444343 @default.
- W2035528736 hasConcept C98274493 @default.
- W2035528736 hasConceptScore W2035528736C121608353 @default.
- W2035528736 hasConceptScore W2035528736C126322002 @default.
- W2035528736 hasConceptScore W2035528736C142724271 @default.
- W2035528736 hasConceptScore W2035528736C167734588 @default.
- W2035528736 hasConceptScore W2035528736C184235292 @default.
- W2035528736 hasConceptScore W2035528736C2776087337 @default.
- W2035528736 hasConceptScore W2035528736C2776539811 @default.
- W2035528736 hasConceptScore W2035528736C2777025900 @default.
- W2035528736 hasConceptScore W2035528736C2778820342 @default.
- W2035528736 hasConceptScore W2035528736C2779217266 @default.
- W2035528736 hasConceptScore W2035528736C2779490328 @default.
- W2035528736 hasConceptScore W2035528736C2779699572 @default.
- W2035528736 hasConceptScore W2035528736C2780394083 @default.